QDEL Stock Price Chart More Charts

QDEL Price/Volume Stats

Quidel Corporation (QDEL) Company Bio

Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications primarily in infectious diseases, women’s health, and gastrointestinal diseases. The company was founded in 1979 and is based in San Diego, California.

QDEL Price Forecast Based on DCF Valuation

We started the process of determining a valid price forecast for Quidel Corp with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Quidel Corp ranked in the 79st percentile in terms of potential gain offered. Specifically, our DCF analysis implies the stock is trading below its fair value by an estimated 231.83%. The most interesting components of our discounted cash flow analysis for Quidel Corp ended up being:

• The company's balance sheet shows it gets 97% of its capital from equity, and 3% of its capital from debt. Its equity weight surpasses that of 75.86% of free cash flow generating stocks in the Healthcare sector.
• Its compound free cash flow growth rate, as measured over the past 5.31 years, is 0.71% -- higher than 88.21% of stocks in our DCF forecasting set.
• The business' balance sheet reveals debt to be 3% of the company's capital (with equity being the remaining amount). Approximately merely 12.6% of US stocks with free cash flow have a lower reliance on debt in their capital structure.

Want more companies with a valuation profile/forecast similar to that of Quidel Corp? See ABC, PCRX, CCEL, ACHC, and INVA.